Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Ballaré, Cecilia Julia
  • Blanco, Enrique
  • Di Croce, Luciano
  • Gomis, Roger R.
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER+) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize., We also thank V. Raker for her editing support. A.L. and I.E. are supported by FPI-SO grants and A.B. and C.F.-P. by FPI Fellowship grants from Gobierno de España. M.F. is supported by the Horizon 2020 Research and Innovation Programme under Marie Skłodowska–Curie grant agreement no. 955951; M.T.B. is supported by an AECC (Spanish Cancer Association) postdoctoral grant, M.N. and R.R.G. by an AECC grant Proyecto GCTRA18006CARR. R.R.G. and L.D.C. are supported by the Institució Catalana de Recerca i Estudis Avançats. Special thanks go to Carme Segura Capellades for generously supporting our endeavours. Support and structural funds were provided by the Generalitat de Catalunya (2021-SGR-00909) to R.R.G., and by the BBVA Foundation, Fundación Científica AECC (PRYGN223207GOMI), the ISCIII/FEDER-CIBERONC, the ‘la Caixa’ Foundation (ID 100010434) under agreement HR17-00092, the FERO Foundation, the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (CIBERONC and PID2019-104948RB-I00; PID2022-143093OB-100) to R.R.G. Work in the L.D.C. laboratory is supported by grants from the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100) and from AGAUR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Ballaré, Cecilia Julia
  • Blanco, Enrique
  • Di Croce, Luciano
  • Gomis, Roger R.
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER+) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize., We also thank V. Raker for her editing support. A.L. and I.E. are supported by FPI-SO grants and A.B. and C.F.-P. by FPI Fellowship grants from Gobierno de España. M.F. is supported by the Horizon 2020 Research and Innovation Programme under Marie Skłodowska–Curie grant agreement no. 955951; M.T.B. is supported by an AECC (Spanish Cancer Association) postdoctoral grant, M.N. and R.R.G. by an AECC grant Proyecto GCTRA18006CARR. R.R.G. and L.D.C. are supported by the Institució Catalana de Recerca i Estudis Avançats. Special thanks go to Carme Segura Capellades for generously supporting our endeavours. Support and structural funds were provided by the Generalitat de Catalunya (2021-SGR-00909) to R.R.G., and by the BBVA Foundation, Fundación Científica AECC (PRYGN223207GOMI), the ISCIII/FEDER-CIBERONC, the ‘la Caixa’ Foundation (ID 100010434) under agreement HR17-00092, the FERO Foundation, the Spanish Ministerio de Economia y Competitividad (MINECO) and FEDER funds (CIBERONC and PID2019-104948RB-I00; PID2022-143093OB-100) to R.R.G. Work in the L.D.C. laboratory is supported by grants from the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) (PID2019-108322GB-100) and from AGAUR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis

  • Llorente, Alicia
  • Blasco, María Teresa
  • Espuny, Irene|||0000-0003-1906-4947
  • Guiu, Marc|||0000-0002-7083-986X
  • Ballaré, Cecilia
  • Blanco, Enrique|||0000-0001-6261-7370
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Bellmunt, Anna|||0000-0002-4810-3848
  • Salvador, Fernando|||0000-0002-0546-1354
  • Morales, Andrea
  • Nuñez, Marc
  • Loren, Guillem
  • Imbastari, Francesca
  • Fidalgo, Marta
  • Figueras-Puig, Cristina|||0000-0003-4457-6864
  • Gibler, Patrizia|||0000-0003-4100-4318
  • Graupera, Mariona|||0000-0003-4608-4185
  • Monteiro, Freddy|||0000-0002-9080-6715
  • Riera, Antoni|||0000-0001-7142-7675
  • Holen, Ingunn|||0000-0002-8759-6913
  • Avgustinova, Alexandra
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Gomis, Roger R..|||0000-0001-6473-2858
MAF amplification increases the risk of breast cancer (BCa) metastasis through mechanisms that are still poorly understood yet have important clinical implications. Oestrogen-receptor-positive (ER) BCa requires oestrogen for both growth and metastasis, albeit by ill-known mechanisms. Here we integrate proteomics, transcriptomics, epigenomics, chromatin accessibility and functional assays from human and syngeneic mouse BCa models to show that MAF directly interacts with oestrogen receptor alpha (ERα), thereby promoting a unique chromatin landscape that favours metastatic spread. We identify metastasis-promoting genes that are de novo licensed following oestrogen exposure in a MAF-dependent manner. The histone demethylase KDM1A is key to the epigenomic remodelling that facilitates the expression of the pro-metastatic MAF/oestrogen-driven gene expression program, and loss of KDM1A activity prevents this metastasis. We have thus determined that the molecular basis underlying MAF/oestrogen-mediated metastasis requires genetic, epigenetic and hormone signals from the systemic environment, which influence the ability of BCa cells to metastasize.